{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:45:22Z","timestamp":1772192722325,"version":"3.50.1"},"reference-count":185,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T00:00:00Z","timestamp":1294963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00005-010-0108-8","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T21:39:31Z","timestamp":1294954771000},"page":"25-40","source":"Crossref","is-referenced-by-count":29,"title":["Tuning of CD40\u2013CD154 Interactions in Human B-Lymphocyte Activation: A Broad Array of In Vitro Models for a Complex In Vivo Situation"],"prefix":"10.2478","volume":"59","author":[{"given":"Sonia","family":"N\u00e9ron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe J.","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Darveau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2011,1,14]]},"reference":[{"key":"108_CR1","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1182\/blood.V96.6.2219","volume":"96","author":"NS Andersen","year":"2000","unstructured":"Andersen NS, Larsen JK, Christiansen J et al (2000) Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures. Blood 96:2219\u20132225","journal-title":"Blood"},{"key":"108_CR2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.CIR.0000028962.04520.01","volume":"106","author":"P Andre","year":"2002","unstructured":"Andre P, Nannizzi-Alaimo L, Prasad SK et al (2002) Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106:896\u2013899","journal-title":"Circulation"},{"key":"108_CR3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/357080a0","volume":"357","author":"RJ Armitage","year":"1992","unstructured":"Armitage RJ, Fanslow WC, Strockbine L et al (1992) Molecular and biological characterization of a murine ligand for CD40. Nature 357:80\u201382","journal-title":"Nature"},{"key":"108_CR4","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1126\/science.7537388","volume":"268","author":"C Arpin","year":"1995","unstructured":"Arpin C, Dechanet J, Van Kooten C et al (1995) Generation of memory B cells and plasma cells in vitro. Science 268:720\u2013722","journal-title":"Science"},{"key":"108_CR5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1084\/jem.186.6.931","volume":"186","author":"C Arpin","year":"1997","unstructured":"Arpin C, Banchereau J, Liu YJ (1997) Memory B cells are biased towards terminal differentiation: a strategy that may prevent repertoire freezing. J Exp Med 186:931\u2013940","journal-title":"J Exp Med"},{"key":"108_CR6","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.4049\/jimmunol.181.3.1767","volume":"181","author":"DT Avery","year":"2008","unstructured":"Avery DT, Bryant VL, Ma CS et al (2008a) IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4. J Immunol 181:1767\u20131779","journal-title":"J Immunol"},{"key":"108_CR7","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/blood-2008-02-142745","volume":"112","author":"DT Avery","year":"2008","unstructured":"Avery DT, Ma CS, Bryant VL et al (2008b) STAT3 is required for IL-21-induced secretion of IgE from human naive B cells. Blood 112:1784\u20131793","journal-title":"Blood"},{"key":"108_CR8","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1182\/blood.V92.8.2830","volume":"92","author":"MP Baker","year":"1998","unstructured":"Baker MP, Eliopoulos AG, Young LS et al (1998) Prolonged phenotypic, functional, and molecular change in group I Burkitt lymphoma cells on short-term exposure to CD40 ligand. Blood 92:2830\u20132843","journal-title":"Blood"},{"key":"108_CR9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/353678a0","volume":"353","author":"J Banchereau","year":"1991","unstructured":"Banchereau J, Rousset F (1991) Growing human B lymphocytes in the CD40 system. Nature 353:678\u2013679","journal-title":"Nature"},{"key":"108_CR10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.1702555","volume":"251","author":"J Banchereau","year":"1991","unstructured":"Banchereau J, de Paoli P, Valle A et al (1991) Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70\u201372","journal-title":"Science"},{"key":"108_CR11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1146\/annurev.iy.12.040194.004313","volume":"12","author":"J Banchereau","year":"1994","unstructured":"Banchereau J, Bazan F, Blanchard D et al (1994) The CD40 antigen and its ligand. Annu Rev Immunol 12:881\u2013922","journal-title":"Annu Rev Immunol"},{"key":"108_CR12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","volume":"18","author":"J Banchereau","year":"2000","unstructured":"Banchereau J, Briere F, Caux C et al (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767\u2013811","journal-title":"Annu Rev Immunol"},{"key":"108_CR13","doi-asserted-by":"crossref","first-page":"9978","DOI":"10.1128\/JVI.01326-08","volume":"82","author":"C Barcia","year":"2008","unstructured":"Barcia C, Gomez A, de Pablos V et al (2008) CD20, CD3, and CD40 ligand microclusters segregate three-dimensionally in vivo at B-cell-T-cell immunological synapses after viral immunity in primate brain. J Virol 82:9978\u20139993","journal-title":"J Virol"},{"key":"108_CR14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2567.2001.01148.x","volume":"102","author":"TA Barr","year":"2001","unstructured":"Barr TA, Heath AW (2001) Functional activity of CD40 antibodies correlates to the position of binding relative to CD154. Immunology 102:39\u201343","journal-title":"Immunology"},{"key":"108_CR15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/35078099","volume":"411","author":"FD Batista","year":"2001","unstructured":"Batista FD, Iber D, Neuberger MS (2001) B cells acquire antigen from target cells after synapse formation. Nature 411:489\u2013494","journal-title":"Nature"},{"key":"108_CR16","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.molimm.2009.02.003","volume":"46","author":"A Batlle","year":"2009","unstructured":"Batlle A, Papadopoulou V, Gomes AR et al (2009) CD40 and B-cell receptor signalling induce MAPK family members that can either induce or repress Bcl-6 expression. Mol Immunol 46:1727\u20131735","journal-title":"Mol Immunol"},{"key":"108_CR17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1359-6101(03)00024-8","volume":"14","author":"GA Bishop","year":"2003","unstructured":"Bishop GA, Hostager BS (2003) The CD40\u2013CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev 14:297\u2013309","journal-title":"Cytokine Growth Factor Rev"},{"key":"108_CR18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-0-387-70630-6_11","volume":"597","author":"GA Bishop","year":"2007","unstructured":"Bishop GA, Moore CR, Xie P et al (2007) TRAF proteins in CD40 signaling. Adv Exp Med Biol 597:131\u2013151","journal-title":"Adv Exp Med Biol"},{"key":"108_CR19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2567.1996.428508.x","volume":"87","author":"P Bjorck","year":"1996","unstructured":"Bjorck P, Paulie S (1996) CD40 antibodies defining distinct epitopes display qualitative differences in their induction of B-cell differentiation. Immunology 87:291\u2013295","journal-title":"Immunology"},{"key":"108_CR20","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.4049\/jimmunol.173.6.3647","volume":"173","author":"J Boisvert","year":"2004","unstructured":"Boisvert J, Edmondson S, Krummel MF (2004) Immunological synapse formation licenses CD40-CD40L accumulations at T-APC contact sites. J Immunol 173:3647\u20133652","journal-title":"J Immunol"},{"key":"108_CR21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.85.2.564","volume":"85","author":"AA Brian","year":"1988","unstructured":"Brian AA (1988) Stimulation of B-cell proliferation by membrane-associated molecules from activated T cells. Proc Natl Acad Sci USA 85:564\u2013568","journal-title":"Proc Natl Acad Sci USA"},{"key":"108_CR22","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.4049\/jimmunol.154.6.2533","volume":"154","author":"N Burdin","year":"1995","unstructured":"Burdin N, Van Kooten C, Galibert L et al (1995) Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J Immunol 154:2533\u20132544","journal-title":"J Immunol"},{"key":"108_CR23","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.4049\/jimmunol.156.11.4107","volume":"156","author":"N Burdin","year":"1996","unstructured":"Burdin N, Galibert L, Garrone P et al (1996) Inability to produce IL-6 is a functional feature of human germinal center B lymphocytes. J Immunol 156:4107\u20134113","journal-title":"J Immunol"},{"key":"108_CR24","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1084\/jem.181.4.1293","volume":"181","author":"M Casamayor-Palleja","year":"1995","unstructured":"Casamayor-Palleja M, Khan M, MacLennan IC (1995) A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J Exp Med 181:1293\u20131301","journal-title":"J Exp Med"},{"key":"108_CR25","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.4049\/jimmunol.151.4.1777","volume":"151","author":"BE Castle","year":"1993","unstructured":"Castle BE, Kishimoto K, Stearns C et al (1993) Regulation of expression of the ligand for CD40 on T helper lymphocytes. J Immunol 151:1777\u20131788","journal-title":"J Immunol"},{"key":"108_CR26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jim.2007.02.008","volume":"322","author":"MP Cayer","year":"2007","unstructured":"Cayer MP, Drouin M, Sea SP et al (2007) Comparison of promoter activities for efficient expression into human B cells and haematopoietic progenitors with adenovirus Ad5\/F35. J Immunol Methods 322:118\u2013127","journal-title":"J Immunol Methods"},{"key":"108_CR27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2249.2009.03917.x","volume":"156","author":"MP Cayer","year":"2009","unstructured":"Cayer MP, Proulx M, Ma XZ et al (2009) c-Src tyrosine kinase co-associates with and phosphorylates signal transducer and activator of transcription 5b which mediates the proliferation of normal human B lymphocytes. Clin Exp Immunol 156:419\u2013427","journal-title":"Clin Exp Immunol"},{"key":"108_CR28","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1182\/blood.V99.9.3411","volume":"99","author":"A Challa","year":"2002","unstructured":"Challa A, Eliopoulos AG, Holder MJ et al (2002) Population depletion activates autonomous CD154-dependent survival in biopsylike Burkitt lymphoma cells. Blood 99:3411\u20133418","journal-title":"Blood"},{"key":"108_CR29","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<508::AID-IMMU508>3.0.CO;2-I","volume":"28","author":"J Choe","year":"1998","unstructured":"Choe J, Choi YS (1998) IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells. Eur J Immunol 28:508\u2013515","journal-title":"Eur J Immunol"},{"key":"108_CR30","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4049\/jimmunol.157.3.1006","volume":"157","author":"J Choe","year":"1996","unstructured":"Choe J, Kim HS, Zhang X et al (1996) Cellular and molecular factors that regulate the differentiation and apoptosis of germinal center B cells. Anti-Ig down-regulates Fas expression of CD40 ligand-stimulated germinal center B cells and inhibits Fas-mediated apoptosis. J Immunol 157:1006\u20131016","journal-title":"J Immunol"},{"key":"108_CR31","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1073\/pnas.83.12.4494","volume":"83","author":"EA Clark","year":"1986","unstructured":"Clark EA, Ledbetter JA (1986) Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci USA 83:4494\u20134498","journal-title":"Proc Natl Acad Sci USA"},{"key":"108_CR32","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.4049\/jimmunol.145.5.1400","volume":"145","author":"EA Clark","year":"1990","unstructured":"Clark EA, Shu G (1990) Association between IL-6 and CD40 signaling. IL-6 induces phosphorylation of CD40 receptors. J Immunol 145:1400\u20131406","journal-title":"J Immunol"},{"key":"108_CR33","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.exphem.2007.05.021","volume":"35","author":"F Cognasse","year":"2007","unstructured":"Cognasse F, Hameh-Cognasse H, Lafarge S et al (2007) Human platelets can activate peripheral blood B cells and increase production of immunoglobulins. Exp Hematol 35:1376\u20131387","journal-title":"Exp Hematol"},{"key":"108_CR34","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0167-5699(99)01507-8","volume":"20","author":"RT Costello","year":"1999","unstructured":"Costello RT, Gastaut JA, Olive D (1999) What is the real role of CD40 in cancer immunotherapy? Immunol Today 20:488\u2013493","journal-title":"Immunol Today"},{"key":"108_CR35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0022-1759(93)90151-V","volume":"159","author":"A Darveau","year":"1993","unstructured":"Darveau A, Chevrier MC, N\u00e9ron S et al (1993) Efficient preparation of human monoclonal antibody-secreting heterohybridomas using peripheral B lymphocytes cultured in the CD40 system. J Immunol Methods 159:139\u2013143","journal-title":"J Immunol Methods"},{"key":"108_CR36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nri2602","volume":"9","author":"DM Davis","year":"2009","unstructured":"Davis DM (2009) Mechanisms and functions for the duration of intercellular contacts made by lymphocytes. Nat Rev Immunol 9:543\u2013555","journal-title":"Nat Rev Immunol"},{"key":"108_CR37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1097-0320(19970215)30:1<33::AID-CYTO5>3.0.CO;2-G","volume":"30","author":"P Paoli De","year":"1997","unstructured":"De Paoli P, Cozzi M, Tedeschi R et al (1997) High CD40 membrane expression in AIDS-related lymphoma B cell lines is associated with the CD45RA+, CD45RO+, CD95+ phenotype and high levels of its soluble form in culture supernatants. Cytometry 30:33\u201338","journal-title":"Cytometry"},{"key":"108_CR38","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1172\/JCI118643","volume":"97","author":"A Desai-Mehta","year":"1996","unstructured":"Desai-Mehta A, Lu L, Ramsey-Goldman R et al (1996) Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 97:2063\u20132073","journal-title":"J Clin Invest"},{"key":"108_CR39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/jaut.1998.0213","volume":"11","author":"BS Devi","year":"1998","unstructured":"Devi BS, Van Noordin S, Krausz T et al (1998) Peripheral blood lymphocytes in SLE\u2013hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. J Autoimmun 11:471\u2013475","journal-title":"J Autoimmun"},{"key":"108_CR40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jim.2009.03.009","volume":"344","author":"E Ducas","year":"2009","unstructured":"Ducas E, Dussault N, Roy A et al (2009) Estimation of the number of CD154 molecules in membrane extracts used as a source of CD40 stimulation of human B lymphocytes. J Immunol Methods 344:133\u2013137","journal-title":"J Immunol Methods"},{"key":"108_CR41","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta R, Benson MJ, de Vries VC et al (2009) Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol Rev 229:152\u2013172","journal-title":"Immunol Rev"},{"key":"108_CR42","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4049\/jimmunol.0900528","volume":"184","author":"T Elmetwali","year":"2010","unstructured":"Elmetwali T, Young LS, Palmer DH (2010) CD40 ligand-induced carcinoma cell death: a balance between activation of TNFR-associated factor (TRAF) 3-dependent death signals and suppression of TRAF6-dependent survival signals. J Immunol 184:1111\u20131120","journal-title":"J Immunol"},{"key":"108_CR43","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1073\/pnas.91.10.4392","volume":"91","author":"JM Eris","year":"1994","unstructured":"Eris JM, Basten A, Brink R et al (1994) Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci USA 91:4392\u20134396","journal-title":"Proc Natl Acad Sci USA"},{"key":"108_CR44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/smim.1994.1035","volume":"6","author":"WC Fanslow","year":"1994","unstructured":"Fanslow WC, Srinivasan S, Paxton R et al (1994) Structural characteristics of CD40 ligand that determine biological function. Semin Immunol 6:267\u2013278","journal-title":"Semin Immunol"},{"key":"108_CR45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/978-1-4615-1971-3_90","volume":"378","author":"J Fayette","year":"1995","unstructured":"Fayette J, Dubois B, Caux C et al (1995) Human dendritic cells can drive CD40-activated sIgD+ B cells to mount mucosal-type humoral response. Adv Exp Med Biol 378:401\u2013403","journal-title":"Adv Exp Med Biol"},{"key":"108_CR46","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.4049\/jimmunol.171.9.4621","volume":"171","author":"JF Fecteau","year":"2003","unstructured":"Fecteau JF, N\u00e9ron S (2003) CD40 stimulation of human peripheral B lymphocytes: distinct response from na\u00efve and memory cells. J Immunol 171:4621\u20134629","journal-title":"J Immunol"},{"key":"108_CR47","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.4049\/jimmunol.177.6.3728","volume":"177","author":"JF Fecteau","year":"2006","unstructured":"Fecteau JF, C\u00f4t\u00e9 G, N\u00e9ron S (2006) A new memory CD27\u2212IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 177:3728\u20133736","journal-title":"J Immunol"},{"issue":"suppl 1","key":"108_CR48","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1111\/j.1365-2567.2008.02976.x","volume":"128","author":"JF Fecteau","year":"2009","unstructured":"Fecteau JF, Roy A, Neron S (2009) Peripheral blood CD27(+) IgG(+) B cells rapidly proliferate and differentiate into immunoglobulin-secreting cells after exposure to low CD154 interaction. Immunology 128(suppl 1):e353\u2013e365","journal-title":"Immunology"},{"key":"108_CR49","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.4049\/jimmunol.162.7.4037","volume":"162","author":"GS Ford","year":"1999","unstructured":"Ford GS, Barnhart B, Shone S et al (1999) Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation. J Immunol 162:4037\u20134044","journal-title":"J Immunol"},{"key":"108_CR50","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood-2004-03-1055","volume":"105","author":"LE French","year":"2005","unstructured":"French LE, Huard B, Wysocka M et al (2005) Impaired CD40L signaling is a cause of defective IL-12 and TNF-alpha production in Sezary syndrome: circumvention by hexameric soluble CD40L. Blood 105:219\u2013225","journal-title":"Blood"},{"key":"108_CR51","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri1647","volume":"5","author":"P Friedl","year":"2005","unstructured":"Friedl P, den Boer AT, Gunzer M (2005) Tuning immune responses: Diversity and adaptation of the immunological synapse. Nat Rev Immunol 5:532\u2013545","journal-title":"Nat Rev Immunol"},{"key":"108_CR52","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1365-2249.1996.38746.x","volume":"104","author":"V Friman","year":"1996","unstructured":"Friman V, Hanson LA, Bridon JM et al (1996) IL-10-driven immunoglobulin production by B lymphocytes from IgA-deficient individuals correlates to infection proneness. Clin Exp Immunol 104:432\u2013438","journal-title":"Clin Exp Immunol"},{"key":"108_CR53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4049\/jimmunol.152.1.22","volume":"152","author":"L Galibert","year":"1994","unstructured":"Galibert L, Durand I, Banchereau J et al (1994) CD40-activated surface IgD-positive lymphocytes constitute the long term IL-4-dependent proliferating B cell pool. J Immunol 152:22\u201329","journal-title":"J Immunol"},{"key":"108_CR54","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/eji.1830250316","volume":"25","author":"L Galibert","year":"1995","unstructured":"Galibert L, van Dooren J, Durand I et al (1995) Anti-CD40 plus interleukin-4-activated human naive B cell lines express unmutated immunoglobulin genes with intraclonal heavy chain isotype variability. Eur J Immunol 25:733\u2013737","journal-title":"Eur J Immunol"},{"key":"108_CR55","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1084\/jem.183.5.2075","volume":"183","author":"L Galibert","year":"1996","unstructured":"Galibert L, Burdin N, Barthelemy C et al (1996) Negative selection of human germinal center B cells by prolonged BCR cross-linking. J Exp Med 183:2075\u20132085","journal-title":"J Exp Med"},{"key":"108_CR56","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1084\/jem.182.5.1265","volume":"182","author":"P Garrone","year":"1995","unstructured":"Garrone P, Neidhardt EM, Garcia E et al (1995) Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 182:1265\u20131273","journal-title":"J Exp Med"},{"key":"108_CR57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0014-5793(93)81175-Y","volume":"315","author":"JF Gauchat","year":"1993","unstructured":"Gauchat JF, Aubry JP, Mazzei G et al (1993) Human CD40-ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production. FEBS Lett 315:259\u2013266","journal-title":"FEBS Lett"},{"key":"108_CR58","doi-asserted-by":"crossref","first-page":"890","DOI":"10.4049\/jimmunol.182.2.890","volume":"182","author":"KL Good","year":"2009","unstructured":"Good KL, Avery DT, Tangye SG (2009) Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol 182:890\u2013901","journal-title":"J Immunol"},{"key":"108_CR59","first-page":"373","volume":"84","author":"J Gordon","year":"1991","unstructured":"Gordon J (1991) Human B lymphocytes mature. Clin Exp Immunol 84:373\u2013375","journal-title":"Clin Exp Immunol"},{"key":"108_CR60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0268-960X(95)90040-3","volume":"9","author":"J Gordon","year":"1995","unstructured":"Gordon J (1995) CD40 and its ligand: central players in B lymphocyte survival, growth, and differentiation. Blood Rev 9:53\u201356","journal-title":"Blood Rev"},{"key":"108_CR61","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2567.2000.00074.x","volume":"100","author":"J Gordon","year":"2000","unstructured":"Gordon J, Pound JD (2000) Fortifying B cells with CD154: an engaging tale of many hues. Immunology 100:269\u2013280","journal-title":"Immunology"},{"key":"108_CR62","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.4049\/jimmunol.140.5.1425","volume":"140","author":"J Gordon","year":"1988","unstructured":"Gordon J, Millsum MJ, Guy GR et al (1988) Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. A comparison with IL-4-mediated signaling. J Immunol 140:1425\u20131430","journal-title":"J Immunol"},{"key":"108_CR63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jaut.2006.02.002","volume":"26","author":"A Goules","year":"2006","unstructured":"Goules A, Tzioufas AG, Manousakis MN et al (2006) Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J Autoimmun 26:165\u2013171","journal-title":"J Autoimmun"},{"key":"108_CR64","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/eji.1830250639","volume":"25","author":"D Graf","year":"1995","unstructured":"Graf D, Muller S, Korthauer U et al (1995) A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur J Immunol 25:1749\u20131754","journal-title":"Eur J Immunol"},{"key":"108_CR65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0065-2776(01)76019-1","volume":"76","author":"AC Grammer","year":"2001","unstructured":"Grammer AC, Lipsky PE (2001) CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. Adv Immunol 76:61\u2013178","journal-title":"Adv Immunol"},{"key":"108_CR66","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/art.10287","volume":"46","author":"AC Grammer","year":"2002","unstructured":"Grammer AC, Lipsky PE (2002) CD154\u2013CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosus. Arthritis Rheum 46:1417\u20131429","journal-title":"Arthritis Rheum"},{"key":"108_CR67","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1172\/JCI200319301","volume":"112","author":"AC Grammer","year":"2003","unstructured":"Grammer AC, Slota R, Fischer R et al (2003) Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154\u2013CD40 interactions. J Clin Invest 112:1506\u20131520","journal-title":"J Clin Invest"},{"key":"108_CR68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","volume":"16","author":"IS Grewal","year":"1998","unstructured":"Grewal IS, Flavell RA (1998) CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16:111\u2013135","journal-title":"Annu Rev Immunol"},{"key":"108_CR69","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.4049\/jimmunol.142.12.4144","volume":"142","author":"MF Gruber","year":"1989","unstructured":"Gruber MF, Bjorndahl JM, Nakamura S et al (1989) Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies. J Immunol 142:4144\u20134152","journal-title":"J Immunol"},{"key":"108_CR70","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<1040::AID-IMMU1040>3.0.CO;2-9","volume":"28","author":"J Hasbold","year":"1998","unstructured":"Hasbold J, Lyons AB, Kehry MR et al (1998) Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4. Eur J Immunol 28:1040\u20131051","journal-title":"Eur J Immunol"},{"key":"108_CR71","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.4049\/jimmunol.163.8.4175","volume":"163","author":"J Hasbold","year":"1999","unstructured":"Hasbold J, Hong JS, Kehry MR et al (1999) Integrating signals from IFN-gamma and IL-4 by B cells: positive and negative effects on CD40 ligand-induced proliferation, survival, and division-linked isotype switching to IgG1, IgE, and IgG2a. J Immunol 163:4175\u20134181","journal-title":"J Immunol"},{"key":"108_CR72","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.it.2009.01.004","volume":"30","author":"GS Hassan","year":"2009","unstructured":"Hassan GS, Merhi Y, Mourad WM (2009) CD154 and its receptors in inflammatory vascular pathologies. Trends Immunol 30:165\u2013172","journal-title":"Trends Immunol"},{"key":"108_CR73","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1002\/1521-4141(2001010)31:10<3094::AID-IMMU3094>3.0.CO;2-F","volume":"31","author":"LE Haswell","year":"2001","unstructured":"Haswell LE, Glennie MJ, Al-Shamkhani A (2001) Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154. Eur J Immunol 31:3094\u20133100","journal-title":"Eur J Immunol"},{"key":"108_CR74","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2249.2009.03996.x","volume":"158","author":"S Heidt","year":"2009","unstructured":"Heidt S, Roelen DL, Eijsink C et al (2009) Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production. Clin Exp Immunol 158:99\u2013105","journal-title":"Clin Exp Immunol"},{"key":"108_CR75","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1182\/blood.V98.4.1047","volume":"98","author":"V Henn","year":"2001","unstructured":"Henn V, Steinbach S, Buchner K et al (2001) The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98:1047\u20131054","journal-title":"Blood"},{"key":"108_CR76","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1182\/blood.V93.9.2999","volume":"93","author":"A Hirano","year":"1999","unstructured":"Hirano A, Longo DL, Taub DD et al (1999) Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand. Blood 93:2999\u20133007","journal-title":"Blood"},{"key":"108_CR77","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.4049\/jimmunol.145.7.2025","volume":"145","author":"PD Hodgkin","year":"1990","unstructured":"Hodgkin PD, Yamashita LC, Coffman RL et al (1990) Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. J Immunol 145:2025\u20132034","journal-title":"J Immunol"},{"key":"108_CR78","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.4049\/jimmunol.147.11.3696","volume":"147","author":"PD Hodgkin","year":"1991","unstructured":"Hodgkin PD, Yamashita LC, Seymour B et al (1991) Membranes from both Th1 and Th2 T cell clones stimulate B cell proliferation and prepare B cells for lymphokine-induced differentiation to secrete Ig. J Immunol 147:3696\u20133702","journal-title":"J Immunol"},{"key":"108_CR79","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1002\/j.1460-2075.1992.tb05530.x","volume":"11","author":"D Hollenbaugh","year":"1992","unstructured":"Hollenbaugh D, Grosmaire LS, Kullas CD et al (1992) The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 11:4313\u20134321","journal-title":"EMBO J"},{"key":"108_CR80","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12026-007-0082-3","volume":"39","author":"BS Hostager","year":"2007","unstructured":"Hostager BS (2007) Roles of TRAF6 in CD40 signaling. Immunol Res 39:105\u2013114","journal-title":"Immunol Res"},{"key":"108_CR81","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/14653240510018055","volume":"7","author":"R Ivanov","year":"2005","unstructured":"Ivanov R, Aarts T, Hagenbeek A et al (2005) B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC. Cytotherapy 7:62\u201373","journal-title":"Cytotherapy"},{"key":"108_CR82","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.172.6.1861","volume":"172","author":"HH Jabara","year":"1990","unstructured":"Jabara HH, Fu SM, Geha RS et al (1990) CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J Exp Med 172:1861\u20131864","journal-title":"J Exp Med"},{"key":"108_CR83","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.4049\/jimmunol.159.5.2282","volume":"159","author":"AI Jaiswal","year":"1997","unstructured":"Jaiswal AI, Croft M (1997) CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response. J Immunol 159:2282\u20132291","journal-title":"J Immunol"},{"key":"108_CR84","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/intimm\/10.8.1083","volume":"10","author":"C Johnson-Leger","year":"1998","unstructured":"Johnson-Leger C, Christensen J, Klaus GG (1998) CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells. Int Immunol 10:1083\u20131091","journal-title":"Int Immunol"},{"key":"108_CR85","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4049\/jimmunol.152.2.438","volume":"152","author":"MD Jumper","year":"1994","unstructured":"Jumper MD, Splawski JB, Lipsky PE et al (1994) Ligation of CD40 induces sterile transcripts of multiple Ig H chain isotypes in human B cells. J Immunol 152:438\u2013445","journal-title":"J Immunol"},{"key":"108_CR86","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.4049\/jimmunol.155.5.2369","volume":"155","author":"MD Jumper","year":"1995","unstructured":"Jumper MD, Nishioka Y, Davis LS et al (1995) Regulation of human B cell function by recombinant CD40 ligand and other TNF-related ligands. J Immunol 155:2369\u20132378","journal-title":"J Immunol"},{"key":"108_CR87","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jim.2005.06.010","volume":"304","author":"D Jung","year":"2005","unstructured":"Jung D, N\u00e9ron S, Drouin M et al (2005) Efficient gene transfer into normal human B lymphocytes with the chimeric adenoviral vector Ad5\/F35. J Immunol Methods 304:78\u201387","journal-title":"J Immunol Methods"},{"key":"108_CR88","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2567.2008.02991.x","volume":"127","author":"DA Kaminski","year":"2009","unstructured":"Kaminski DA, Lee BO, Eaton SM et al (2009) CD28 and inducible costimulator (ICOS) signalling can sustain CD154 expression on activated T cells. Immunology 127:373\u2013385","journal-title":"Immunology"},{"key":"108_CR89","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2141.2004.05225.x","volume":"127","author":"AP Kater","year":"2004","unstructured":"Kater AP, Evers LM, Remmerswaal EB et al (2004) CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack. Br J Haematol 127:404\u2013415","journal-title":"Br J Haematol"},{"key":"108_CR90","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1172\/JCI7014","volume":"104","author":"K Kato","year":"1999","unstructured":"Kato K, Santana-Sahagun E, Rassenti LZ et al (1999) The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J Clin Invest 104:947\u2013955","journal-title":"J Clin Invest"},{"key":"108_CR91","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/smim.1994.1037","volume":"6","author":"MR Kehry","year":"1994","unstructured":"Kehry MR, Castle BE (1994) Regulation of CD40 ligand expression and use of recombinant CD40 ligand for studying B cell growth and differentiation. Semin Immunol 6:287\u2013294","journal-title":"Semin Immunol"},{"key":"108_CR92","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1615\/CritRevImmunol.v14.i3-4.20","volume":"14","author":"MR Kehry","year":"1994","unstructured":"Kehry MR, Hodgkin PD (1994) B-cell activation by helper T-cell membranes. Crit Rev Immunol 14:221\u2013238","journal-title":"Crit Rev Immunol"},{"key":"108_CR93","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.yexmp.2005.12.004","volume":"80","author":"MO Kilinc","year":"2006","unstructured":"Kilinc MO, Mukundan L, Yolcu ES et al (2006) Generation of a multimeric form of CD40L with potent immunostimulatory activity using streptavidin as a chaperon. Exp Mol Pathol 80:252\u2013261","journal-title":"Exp Mol Pathol"},{"key":"108_CR94","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2006-12-061648","volume":"110","author":"MA Kilmon","year":"2007","unstructured":"Kilmon MA, Wagner NJ, Garland AL et al (2007) Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6. Blood 110:1595\u20131602","journal-title":"Blood"},{"key":"108_CR95","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/smim.1994.1036","volume":"6","author":"SJ Klaus","year":"1994","unstructured":"Klaus SJ, Berberich I, Shu G et al (1994) CD40 and its ligand in the regulation of humoral immunity. Semin Immunol 6:279\u2013286","journal-title":"Semin Immunol"},{"key":"108_CR96","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1365-2249.2002.01932.x","volume":"129","author":"N Kobayashi","year":"2002","unstructured":"Kobayashi N, Nagumo H, Agematsu K (2002) IL-10 enhances B-cell IgE synthesis by promoting differentiation into plasma cells, a process that is inhibited by CD27\/CD70 interaction. Clin Exp Immunol 129:446\u2013452","journal-title":"Clin Exp Immunol"},{"key":"108_CR97","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood-2007-03-081299","volume":"110","author":"Y Koguchi","year":"2007","unstructured":"Koguchi Y, Thauland TJ, Slifka MK et al (2007) Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific manner. Blood 110:2520\u20132527","journal-title":"Blood"},{"key":"108_CR98","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2249.2008.03820.x","volume":"155","author":"E Kondo","year":"2009","unstructured":"Kondo E, Gryschok L, Klein-Gonzalez N et al (2009a) CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential. Clin Exp Immunol 155:249\u2013256","journal-title":"Clin Exp Immunol"},{"key":"108_CR99","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/CJI.0b013e31819031a2","volume":"32","author":"E Kondo","year":"2009","unstructured":"Kondo E, Gryschok L, Schultze JL et al (2009b) Using CD40-activated B Cells to efficiently identify epitopes of tumor antigens. J Immunother 32:157\u2013160","journal-title":"J Immunother"},{"key":"108_CR100","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1172\/JCI118855","volume":"98","author":"M Koshy","year":"1996","unstructured":"Koshy M, Berger D, Crow MK (1996) Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 98:826\u2013837","journal-title":"J Clin Invest"},{"key":"108_CR101","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.177.4.1209","volume":"177","author":"P Lane","year":"1993","unstructured":"Lane P, Brocker T, Hubele S et al (1993) Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J Exp Med 177:1209\u20131213","journal-title":"J Exp Med"},{"key":"108_CR102","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/eji.1830250646","volume":"25","author":"P Lane","year":"1995","unstructured":"Lane P, Burdet C, McConnell F et al (1995) CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation. Eur J Immunol 25:1788\u20131793","journal-title":"Eur J Immunol"},{"key":"108_CR103","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/eji.1830261016","volume":"26","author":"R Lapointe","year":"1996","unstructured":"Lapointe R, Lemieux R, Olivier M et al (1996) Tyrosine kinase and cAMP-dependent protein kinase activities in CD40-activated human B lymphocytes. Eur J Immunol 26:2376\u20132382","journal-title":"Eur J Immunol"},{"key":"108_CR104","first-page":"2836","volume":"63","author":"R Lapointe","year":"2003","unstructured":"Lapointe R, Bellemare-Pelletier A, Housseau F et al (2003) CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Res 63:2836\u20132843","journal-title":"Cancer Res"},{"key":"108_CR105","first-page":"67","volume":"44","author":"JA Ledbetter","year":"1994","unstructured":"Ledbetter JA, Grosmaire LS, Hollenbaugh D et al (1994) Agonistic and antagonistic properties of CD40 mAb G28-5 are dependent on binding valency. Circ Shock 44:67\u201372","journal-title":"Circ Shock"},{"key":"108_CR106","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.20020845","volume":"196","author":"BO Lee","year":"2002","unstructured":"Lee BO, Haynes L, Eaton SM et al (2002) The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12. J Exp Med 196:693\u2013704","journal-title":"J Exp Med"},{"key":"108_CR107","doi-asserted-by":"crossref","first-page":"10717","DOI":"10.1073\/pnas.0601539103","volume":"103","author":"R Lesley","year":"2006","unstructured":"Lesley R, Kelly LM, Xu Y et al (2006) Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survival. Proc Natl Acad Sci USA 103:10717\u201310722","journal-title":"Proc Natl Acad Sci USA"},{"key":"108_CR108","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1189\/jlb.0907615","volume":"83","author":"N Li","year":"2008","unstructured":"Li N (2008) Platelet\u2013lymphocyte cross-talk. J Leukoc Biol 83:1069\u20131078","journal-title":"J Leukoc Biol"},{"key":"108_CR109","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1365-2141.2001.02806.x","volume":"113","author":"MM Loembe","year":"2001","unstructured":"Loembe MM, Lamoureux J, Deslauriers N et al (2001) Lack of CD40-dependent B-cell proliferation in B lymphocytes isolated from patients with persistent polyclonal B-cell lymphocytosis. Br J Haematol 113:699\u2013705","journal-title":"Br J Haematol"},{"key":"108_CR110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.smim.2009.07.001","volume":"21","author":"AS Loskog","year":"2009","unstructured":"Loskog AS, Eliopoulos AG (2009) The Janus faces of CD40 in cancer. Semin Immunol 21:301\u2013307","journal-title":"Semin Immunol"},{"key":"108_CR111","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1182\/blood-2003-12-4146","volume":"104","author":"T Luft","year":"2004","unstructured":"Luft T, Maraskovsky E, Schnurr M et al (2004) Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells. Blood 104:1066\u20131074","journal-title":"Blood"},{"key":"108_CR112","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.smim.2009.05.010","volume":"21","author":"DY Ma","year":"2009","unstructured":"Ma DY, Clark EA (2009) The role of CD40 and CD154\/CD40L in dendritic cells. Semin Immunol 21:265\u2013272","journal-title":"Semin Immunol"},{"key":"108_CR113","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1172\/JCI119781","volume":"100","author":"KP MacDonald","year":"1997","unstructured":"MacDonald KP, Nishioka Y, Lipsky PE et al (1997) Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest 100:2404\u20132414","journal-title":"J Clin Invest"},{"key":"108_CR114","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1084\/jem.183.3.937","volume":"183","author":"F Malisan","year":"1996","unstructured":"Malisan F, Briere F, Bridon JM et al (1996) Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes. J Exp Med 183:937\u2013947","journal-title":"J Exp Med"},{"key":"108_CR115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-3083.2003.01271.x","volume":"57","author":"AC Malmborg Hager","year":"2003","unstructured":"Malmborg Hager AC, Ellmark P, Borrebaeck CA et al (2003) Affinity and epitope profiling of mouse anti-CD40 monoclonal antibodies. Scand J Immunol 57:517\u2013524","journal-title":"Scand J Immunol"},{"key":"108_CR116","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nm1045","volume":"10","author":"RK Mathur","year":"2004","unstructured":"Mathur RK, Awasthi A, Wadhone P et al (2004) Reciprocal CD40 signals through p38MAPK and ERK-1\/2 induce counteracting immune responses. Nat Med 10:540\u2013544","journal-title":"Nat Med"},{"key":"108_CR117","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1074\/jbc.270.13.7025","volume":"270","author":"GJ Mazzei","year":"1995","unstructured":"Mazzei GJ, Edgerton MD, Losberger C et al (1995) Recombinant soluble trimeric CD40 ligand is biologically active. J Biol Chem 270:7025\u20137028","journal-title":"J Biol Chem"},{"key":"108_CR118","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.4049\/jimmunol.169.5.2736","volume":"169","author":"JF McDyer","year":"2002","unstructured":"McDyer JF, Li Z, John S et al (2002) IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production. J Immunol 169:2736\u20132746","journal-title":"J Immunol"},{"key":"108_CR119","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.158.10.4620","volume":"158","author":"T Miyashita","year":"1997","unstructured":"Miyashita T, McIlraith MJ, Grammer AC et al (1997) Bidirectional regulation of human B cell responses by CD40\u2013CD40 ligand interactions. J Immunol 158:4620\u20134633","journal-title":"J Immunol"},{"key":"108_CR120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/25764","volume":"395","author":"CR Monks","year":"1998","unstructured":"Monks CR, Freiberg BA, Kupfer H et al (1998) Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395:82\u201386","journal-title":"Nature"},{"key":"108_CR121","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1074\/jbc.274.1.418","volume":"274","author":"AE Morris","year":"1999","unstructured":"Morris AE, Remmele RL Jr, Klinke R et al (1999) Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD154). J Biol Chem 274:418\u2013423","journal-title":"J Biol Chem"},{"key":"108_CR122","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.smim.2009.05.008","volume":"21","author":"ME Munroe","year":"2009","unstructured":"Munroe ME (2009) Functional roles for T cell CD40 in infection and autoimmune disease: the role of CD40 in lymphocyte homeostasis. Semin Immunol 21:283\u2013288","journal-title":"Semin Immunol"},{"key":"108_CR123","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.4049\/jimmunol.161.12.6496","volume":"161","author":"H Nagumo","year":"1998","unstructured":"Nagumo H, Agematsu K, Shinozaki K et al (1998) CD27\/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells. J Immunol 161:6496\u20136502","journal-title":"J Immunol"},{"key":"108_CR124","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V99.2.567","volume":"99","author":"H Nagumo","year":"2002","unstructured":"Nagumo H, Agematsu K, Kobayashi N et al (2002) The different process of class switching and somatic hypermutation; a novel analysis by (CD27-) na\u00efve B cells. Blood 99:567\u2013575","journal-title":"Blood"},{"key":"108_CR125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08820139609059292","volume":"25","author":"S N\u00e9ron","year":"1996","unstructured":"N\u00e9ron S, Pelletier A, Chevrier MC et al (1996) Induction of LFA-1 independent human B cell proliferation and differentiation by binding of CD40 with its ligand. Immunol Invest 25:79\u201389","journal-title":"Immunol Invest"},{"key":"108_CR126","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2567.2005.02244.x","volume":"116","author":"S N\u00e9ron","year":"2005","unstructured":"N\u00e9ron S, Racine C, Roy A et al (2005) Differential responses of human B-lymphocyte subpopulations to graded levels of CD40\u2013CD154 interaction. Immunology 116:454\u2013463","journal-title":"Immunology"},{"key":"108_CR127","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/intimm\/dxh377","volume":"18","author":"S N\u00e9ron","year":"2006","unstructured":"N\u00e9ron S, Suck G, Ma XZ et al (2006) B cell proliferation following CD40 stimulation results in the expression and activation of Src protein tyrosine kinase. Int Immunol 18:375\u2013387","journal-title":"Int Immunol"},{"key":"108_CR128","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1073\/pnas.89.14.6550","volume":"89","author":"RJ Noelle","year":"1992","unstructured":"Noelle RJ, Roy M, Shepherd DM et al (1992) A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 89:6550\u20136554","journal-title":"Proc Natl Acad Sci USA"},{"key":"108_CR129","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-065X.2009.00774.x","volume":"229","author":"MA Nolte","year":"2009","unstructured":"Nolte MA, van Olffen RW, van Gisbergen K et al (2009) Timing and tuning of CD27\u2013CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev 229:216\u2013231","journal-title":"Immunol Rev"},{"key":"108_CR130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.imlet.2007.11.005","volume":"116","author":"JY Park","year":"2008","unstructured":"Park JY, Yoon SH, Kim EK et al (2008) A membrane-bound form of IL-4 enhances proliferation and antigen presentation of CD40-activated human B cells. Immunol Lett 116:33\u201340","journal-title":"Immunol Lett"},{"key":"108_CR131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00199769","volume":"20","author":"S Paulie","year":"1985","unstructured":"Paulie S, Ehlin-Henriksson B, Mellstedt H et al (1985) A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol Immunother 20:23\u201328","journal-title":"Cancer Immunol Immunother"},{"key":"108_CR132","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4049\/jimmunol.142.2.590","volume":"142","author":"S Paulie","year":"1989","unstructured":"Paulie S, Rosen A, Ehlin-Henriksson B et al (1989) The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction. J Immunol 142:590\u2013595","journal-title":"J Immunol"},{"key":"108_CR133","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.4049\/jimmunol.141.6.1891","volume":"141","author":"GA Peltz","year":"1988","unstructured":"Peltz GA, Trounstine ML, Moore KW (1988) Cloned and expressed human Fc receptor for IgG mediates anti-CD3-dependent lymphoproliferation. J Immunol 141:1891\u20131896","journal-title":"J Immunol"},{"key":"108_CR134","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.4049\/jimmunol.160.3.1166","volume":"160","author":"X Peng","year":"1998","unstructured":"Peng X, Remacle JE, Kasran A et al (1998) IL-12 up-regulates CD40 ligand (CD154) expression on human T cells. J Immunol 160:1166\u20131172","journal-title":"J Immunol"},{"key":"108_CR135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.smim.2009.05.012","volume":"21","author":"AL Peters","year":"2009","unstructured":"Peters AL, Stunz LL, Bishop GA (2009) CD40 and autoimmunity: the dark side of a great activator. Semin Immunol 21:293\u2013300","journal-title":"Semin Immunol"},{"key":"108_CR136","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1074\/jbc.271.11.5965","volume":"271","author":"F Pietravalle","year":"1996","unstructured":"Pietravalle F, Lecoanet-Henchoz S, Blasey H et al (1996) Human native soluble CD40L is a biologically active trimer, processed inside microsomes. J Biol Chem 271:5965\u20135967","journal-title":"J Biol Chem"},{"key":"108_CR137","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/intimm\/11.1.11","volume":"11","author":"JD Pound","year":"1999","unstructured":"Pound JD, Challa A, Holder MJ et al (1999) Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells. Int Immunol 11:11\u201320","journal-title":"Int Immunol"},{"key":"108_CR138","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1546-0096-6-8","volume":"6","author":"S Prahalad","year":"2008","unstructured":"Prahalad S, Martins TB, Tebo AE et al (2008) Elevated serum levels of soluble CD154 in children with juvenile idiopathic arthritis. Pediatr Rheumatol Online J 6:8","journal-title":"Pediatr Rheumatol Online J"},{"key":"108_CR139","doi-asserted-by":"crossref","first-page":"11836","DOI":"10.1021\/bi981067q","volume":"37","author":"SS Pullen","year":"1998","unstructured":"Pullen SS, Miller HG, Everdeen DS et al (1998) CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry 37:11836\u201311845","journal-title":"Biochemistry"},{"key":"108_CR140","doi-asserted-by":"crossref","first-page":"14246","DOI":"10.1074\/jbc.274.20.14246","volume":"274","author":"SS Pullen","year":"1999","unstructured":"Pullen SS, Dang TT, Crute JJ et al (1999) CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs. J Biol Chem 274:14246\u201314254","journal-title":"J Biol Chem"},{"key":"108_CR141","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.immunol.22.012703.104533","volume":"22","author":"SA Quezada","year":"2004","unstructured":"Quezada SA, Jarvinen LZ, Lind EF et al (2004) CD40\/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 22:307\u2013328","journal-title":"Annu Rev Immunol"},{"key":"108_CR142","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1074-7613(00)80578-6","volume":"8","author":"TD Randall","year":"1998","unstructured":"Randall TD, Heath AW, Santos-Argumedo L et al (1998) Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers. Immunity 8:733\u2013742","journal-title":"Immunity"},{"key":"108_CR143","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.179.2.673","volume":"179","author":"CL Ren","year":"1994","unstructured":"Ren CL, Morio T, Fu SM et al (1994) Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase C gamma 2. J Exp Med 179:673\u2013680","journal-title":"J Exp Med"},{"key":"108_CR144","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ni.1750","volume":"10","author":"L Riol-Blanco","year":"2009","unstructured":"Riol-Blanco L, Delgado-Martin C, Sanchez-Sanchez N et al (2009) Immunological synapse formation inhibits, via NF-kappaB and FOXO1, the apoptosis of dendritic cells. Nat Immunol 10:753\u2013760","journal-title":"Nat Immunol"},{"key":"108_CR145","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.molmed.2008.09.006","volume":"14","author":"M Rizvi","year":"2008","unstructured":"Rizvi M, Pathak D, Freedman JE et al (2008) CD40\u2013CD40 ligand interactions in oxidative stress, inflammation and vascular disease. Trends Mol Med 14:530\u2013538","journal-title":"Trends Mol Med"},{"key":"108_CR146","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.173.3.705","volume":"173","author":"F Rousset","year":"1991","unstructured":"Rousset F, Garcia E, Banchereau J (1991) Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med 173:705\u2013710","journal-title":"J Exp Med"},{"key":"108_CR147","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/intimm\/7.8.1243","volume":"7","author":"F Rousset","year":"1995","unstructured":"Rousset F, Peyrol S, Garcia E et al (1995) Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4. Int Immunol 7:1243\u20131253","journal-title":"Int Immunol"},{"key":"108_CR148","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.4049\/jimmunol.151.5.2497","volume":"151","author":"M Roy","year":"1993","unstructured":"Roy M, Waldschmidt T, Aruffo A et al (1993) The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 151:2497\u20132510","journal-title":"J Immunol"},{"key":"108_CR149","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/cimm.2000.1645","volume":"201","author":"N Sakata","year":"2000","unstructured":"Sakata N, Hamelmann E, Siadak AW et al (2000) Differential regulation of CD40-mediated human B cell responses by antibodies directed against different CD40 epitopes. Cell Immunol 201:109\u2013123","journal-title":"Cell Immunol"},{"key":"108_CR150","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1073\/pnas.92.18.8200","volume":"92","author":"JL Schultze","year":"1995","unstructured":"Schultze JL, Cardoso AA, Freeman GJ et al (1995) Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity. Proc Natl Acad Sci USA 92:8200\u20138204","journal-title":"Proc Natl Acad Sci USA"},{"key":"108_CR151","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI119822","volume":"100","author":"JL Schultze","year":"1997","unstructured":"Schultze JL, Michalak S, Seamon MJ et al (1997) CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J Clin Invest 100:2757\u20132765","journal-title":"J Clin Invest"},{"key":"108_CR152","first-page":"558","volume":"9","author":"NV Sipsas","year":"2002","unstructured":"Sipsas NV, Sfikakis PP, Kontos A et al (2002) Levels of soluble CD40 ligand (CD154) in serum are increased in human immunodeficiency virus type 1-infected patients and correlate with CD4(+) T-cell counts. Clin Diagn Lab Immunol 9:558\u2013561","journal-title":"Clin Diagn Lab Immunol"},{"key":"108_CR153","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.4049\/jimmunol.164.7.3500","volume":"164","author":"S Skov","year":"2000","unstructured":"Skov S, Bonyhadi M, Odum N et al (2000) IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells. J Immunol 164:3500\u20133505","journal-title":"J Immunol"},{"key":"108_CR154","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1182\/blood-2006-12-062943","volume":"109","author":"JT Snyder","year":"2007","unstructured":"Snyder JT, Shen J, Azmi H et al (2007) Direct inhibition of CD40L expression can contribute to the clinical efficacy of daclizumab independently of its effects on cell division and Th1\/Th2 cytokine production. Blood 109:5399\u20135406","journal-title":"Blood"},{"key":"108_CR155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00005-009-0032-y","volume":"57","author":"JM Sowa","year":"2009","unstructured":"Sowa JM, Crist SA, Ratliff TL et al (2009) Platelet influence on T- and B-cell responses. Arch Immunol Ther Exp 57:235\u2013241","journal-title":"Arch Immunol Ther Exp"},{"key":"108_CR156","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4049\/jimmunol.150.4.1276","volume":"150","author":"JB Splawski","year":"1993","unstructured":"Splawski JB, Fu SM, Lipsky PE (1993) Immunoregulatory role of CD40 in human B cell differentiation. J Immunol 150:1276\u20131285","journal-title":"J Immunol"},{"key":"108_CR157","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1084\/jem.176.6.1543","volume":"176","author":"MK Spriggs","year":"1992","unstructured":"Spriggs MK, Armitage RJ, Strockbine L et al (1992) Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 176:1543\u20131550","journal-title":"J Exp Med"},{"key":"108_CR158","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.4049\/jimmunol.179.5.2705","volume":"179","author":"R Stewart","year":"2007","unstructured":"Stewart R, Wei W, Challa A et al (2007) CD154 tone sets the signaling pathways and transcriptome generated in model CD40-pluricompetent L3055 Burkitt\u2019s lymphoma cells. J Immunol 179:2705\u20132712","journal-title":"J Immunol"},{"key":"108_CR159","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.4049\/jimmunol.162.11.6690","volume":"162","author":"CS Subauste","year":"1999","unstructured":"Subauste CS, Wessendarp M, Sorensen RU et al (1999) CD40\u2013CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. J Immunol 162:6690\u20136700","journal-title":"J Immunol"},{"key":"108_CR160","first-page":"2583","volume":"28","author":"N Tamura","year":"2001","unstructured":"Tamura N, Kobayashi S, Kato K et al (2001) Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis. J Rheumatol 28:2583\u20132590","journal-title":"J Rheumatol"},{"key":"108_CR161","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4049\/jimmunol.179.1.13","volume":"179","author":"SG Tangye","year":"2007","unstructured":"Tangye SG, Good KL (2007) Human IgM+CD27+ B cells: memory B cells or \u201cmemory\u201d B cells? J Immunol 179:13\u201319","journal-title":"J Immunol"},{"key":"108_CR162","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.188.9.1691","volume":"188","author":"SG Tangye","year":"1998","unstructured":"Tangye SG, Liu YJ, Aversa G et al (1998) Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med 188:1691\u20131703","journal-title":"J Exp Med"},{"key":"108_CR163","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.4049\/jimmunol.169.8.4298","volume":"169","author":"SG Tangye","year":"2002","unstructured":"Tangye SG, Ferguson A, Avery DT et al (2002a) Isotype switching by human B cells is division-associated and regulated by cytokines. J Immunol 169:4298\u20134306","journal-title":"J Immunol"},{"key":"108_CR164","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/1521-4141(200206)32:6<1640::AID-IMMU1640>3.0.CO;2-S","volume":"32","author":"SG Tangye","year":"2002","unstructured":"Tangye SG, van de Weerdt BC, Avery DT et al (2002b) CD84 is up-regulated on a major population of human memory B cells and recruits the SH2 domain containing proteins SAP and EAT-2. Eur J Immunol 32:1640\u20131649","journal-title":"Eur J Immunol"},{"key":"108_CR165","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4049\/jimmunol.170.2.686","volume":"170","author":"SG Tangye","year":"2003","unstructured":"Tangye SG, Avery DT, Deenick EK et al (2003a) Intrinsic differences in the proliferation of na\u00efve and memory human B cells as a mechanism for enhanced secondary immune responses. J Immunol 170:686\u2013694","journal-title":"J Immunol"},{"key":"108_CR166","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4049\/jimmunol.170.1.261","volume":"170","author":"SG Tangye","year":"2003","unstructured":"Tangye SG, Avery DT, Hodgkin PD (2003b) A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells. J Immunol 170:261\u2013269","journal-title":"J Immunol"},{"key":"108_CR167","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/08916930400002386","volume":"37","author":"E Toubi","year":"2004","unstructured":"Toubi E, Shoenfeld Y (2004) The role of CD40\u2013CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 37:457\u2013464","journal-title":"Autoimmunity"},{"key":"108_CR168","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1182\/blood-2008-04-152041","volume":"112","author":"W Tu","year":"2008","unstructured":"Tu W, Lau YL, Zheng J et al (2008) Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells. Blood 112:2554\u20132562","journal-title":"Blood"},{"key":"108_CR169","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1073\/pnas.0609665104","volume":"104","author":"JJ Unternaehrer","year":"2007","unstructured":"Unternaehrer JJ, Chow A, Pypaert M et al (2007) The tetraspanin CD9 mediates lateral association of MHC class II molecules on the dendritic cell surface. Proc Natl Acad Sci USA 104:234\u2013239","journal-title":"Proc Natl Acad Sci USA"},{"key":"108_CR170","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.V85.7.1903.bloodjournal8571903","volume":"85","author":"M Urashima","year":"1995","unstructured":"Urashima M, Chauhan D, Uchiyama H et al (1995) CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood 85:1903\u20131912","journal-title":"Blood"},{"key":"108_CR171","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3899\/jrheum.080978","volume":"36","author":"M Urquizu-Padilla","year":"2009","unstructured":"Urquizu-Padilla M, Balada E, Cortes F et al (2009) Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus. J Rheumatol 36:953\u2013960","journal-title":"J Rheumatol"},{"key":"108_CR172","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/eji.1830190818","volume":"19","author":"A Valle","year":"1989","unstructured":"Valle A, Zuber CE, Defrance T et al (1989) Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol 19:1463\u20131467","journal-title":"Eur J Immunol"},{"key":"108_CR173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60865-2","volume":"61","author":"C Kooten Van","year":"1996","unstructured":"Van Kooten C, Banchereau J (1996) CD40\u2013CD40 ligand: a multifunctional receptor\u2013ligand pair. Adv Immunol 61:1\u201377","journal-title":"Adv Immunol"},{"key":"108_CR174","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","volume":"67","author":"C Kooten Van","year":"2000","unstructured":"Van Kooten C, Banchereau J (2000) CD40\u2013CD40 ligand. J Leukoc Biol 67:2\u201317","journal-title":"J Leukoc Biol"},{"key":"108_CR175","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1182\/blood.V99.9.3319","volume":"99","author":"M Bergwelt-Baildon von","year":"2002","unstructured":"von Bergwelt-Baildon M, Vonderheide RH, Maecker B et al (2002) Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application. Blood 99:3319\u20133325","journal-title":"Blood"},{"key":"108_CR176","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1158\/0008-5472.CAN-03-3606","volume":"64","author":"M Bergwelt-Baildon von","year":"2004","unstructured":"von Bergwelt-Baildon M, Schultze JL, Maecker B et al (2004) Correspondence re R. Lapointe et al., CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Res 64:4055\u20134056","journal-title":"Cancer Res"},{"key":"108_CR177","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1182\/blood-2004-01-0113","volume":"107","author":"M Bergwelt-Baildon von","year":"2006","unstructured":"von Bergwelt-Baildon M, Shimabukuro-Vornhagen A, Popov A et al (2006) CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants. Blood 107:2786\u20132789","journal-title":"Blood"},{"key":"108_CR178","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.4049\/jimmunol.169.11.6092","volume":"169","author":"SA Wetzel","year":"2002","unstructured":"Wetzel SA, McKeithan TW, Parker DC (2002) Live-cell dynamics and the role of costimulation in immunological synapse formation. J Immunol 169:6092\u20136101","journal-title":"J Immunol"},{"key":"108_CR179","doi-asserted-by":"crossref","first-page":"e1464","DOI":"10.1371\/journal.pone.0001464","volume":"3","author":"M Wiesner","year":"2008","unstructured":"Wiesner M, Zentz C, Mayr C et al (2008) Conditional immortalization of human B cells by CD40 ligation. PLoS One 3:e1464","journal-title":"PLoS One"},{"key":"108_CR180","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4049\/jimmunol.152.2.598","volume":"152","author":"MJ Yellin","year":"1994","unstructured":"Yellin MJ, Sippel K, Inghirami G et al (1994) CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule\/CD40-L. Potential role in regulating helper effector function. J Immunol 152:598\u2013608","journal-title":"J Immunol"},{"key":"108_CR181","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.4049\/jimmunol.165.11.6627","volume":"165","author":"Y Yi","year":"2000","unstructured":"Yi Y, McNerney M, Datta SK (2000) Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells. J Immunol 165:6627\u20136634","journal-title":"J Immunol"},{"key":"108_CR182","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2141.1998.00522.x","volume":"100","author":"A Younes","year":"1998","unstructured":"Younes A, Snell V, Consoli U et al (1998) Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukaemia. Br J Haematol 100:135\u2013141","journal-title":"Br J Haematol"},{"key":"108_CR183","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1600-0854.2009.00913.x","volume":"10","author":"MI Yuseff","year":"2009","unstructured":"Yuseff MI, Lankar D, Lennon-Dumenil AM (2009) Dynamics of membrane trafficking downstream of B and T cell receptor engagement: impact on immune synapses. Traffic 10:629\u2013636","journal-title":"Traffic"},{"key":"108_CR184","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.4049\/jimmunol.0901329","volume":"183","author":"J Zheng","year":"2009","unstructured":"Zheng J, Liu Y, Qin G et al (2009) Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells. J Immunol 183:3742\u20133750","journal-title":"J Immunol"},{"key":"108_CR185","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/cmi.2009.103","volume":"7","author":"J Zheng","year":"2010","unstructured":"Zheng J, Liu Y, Lau YL et al (2010) CD40-activated B cells are more potent than immature dendritic cells to induce and expand CD4(+) regulatory T cells. Cell Mol Immunol 7:44\u201350","journal-title":"Cell Mol Immunol"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-010-0108-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-010-0108-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-010-0108-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T19:22:51Z","timestamp":1740856971000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-010-0108-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,14]]},"references-count":185,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["108"],"URL":"https:\/\/doi.org\/10.1007\/s00005-010-0108-8","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,14]]}}}